These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20716337)

  • 1. The European paediatric legislation: benefits and perspectives.
    Rocchi F; Paolucci P; Ceci A; Rossi P
    Ital J Pediatr; 2010 Aug; 36():56. PubMed ID: 20716337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Rocchi F; Tomasi P
    Pharmacol Res; 2011 Sep; 64(3):169-75. PubMed ID: 21376810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who are the PDCO?
    Dempsey EM; Connolly K
    Eur J Pediatr; 2014 Feb; 173(2):233-5. PubMed ID: 23925423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Framework conditions facilitating paediatric clinical research.
    Knellwolf AL; Bauzon S; Alberighi OD; Lutsar I; Bácsy E; Alfarez D; Panei P
    Ital J Pediatr; 2011 Feb; 37():12. PubMed ID: 21345195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric clinical pharmacology: at the beginning of a new era.
    Hoppu K
    Eur J Clin Pharmacol; 2008 Feb; 64(2):201-5. PubMed ID: 17972069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European Regulation on medicines for paediatric use.
    Dunne J
    Paediatr Respir Rev; 2007 Jun; 8(2):177-83. PubMed ID: 17574163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usage of unpublished paediatric data.
    Saint-Raymond A; Pelle B; Zaccaria C; Sennwitz M; Branch S
    Arch Dis Child; 2016 Jan; 101(1):81-4. PubMed ID: 26543071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medicines for children and "off-label use" 5 years after implementation of the Paediatric Regulation (EC) No 1901/2006. An interim analyis].
    Afentaki A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1111-9. PubMed ID: 25139386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will children with cancer benefit from the new European Paediatric Medicines Regulation?
    Vassal G
    Eur J Cancer; 2009 Jun; 45(9):1535-46. PubMed ID: 19419857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European Medicines Agency workshop on juvenile animal testing for nonclinical assessors.
    Silva-Lima B; Due Theilade-Thomsen M; Carleer J; Vidal JM; Tomasi P; Saint-Raymond A
    Birth Defects Res B Dev Reprod Toxicol; 2010 Dec; 89(6):467-73. PubMed ID: 20632393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European paediatric initiative: 1 year of experience.
    Saint-Raymond A; Seigneuret N
    Paediatr Drugs; 2009; 11(1):9-10. PubMed ID: 19127942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than 5 years of European Paediatric Regulation: statistics and industrial experience.
    Winzenburg G
    Int J Pharm; 2014 Aug; 469(2):260-2. PubMed ID: 24704106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn].
    Riedel C; Lehmann B; Broich K; Sudhop T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Dec; 59(12):1587-1592. PubMed ID: 27778087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
    Mukattash T; Hawwa AF; Trew K; McElnay JC
    Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three years of paediatric regulation in the European Union.
    Olski TM; Lampus SF; Gherarducci G; Saint Raymond A
    Eur J Clin Pharmacol; 2011 Mar; 67(3):245-52. PubMed ID: 21286912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
    Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The status of paediatric medicines initiatives around the world--What has happened and what has not?
    Hoppu K; Anabwani G; Garcia-Bournissen F; Gazarian M; Kearns GL; Nakamura H; Peterson RG; Sri Ranganathan S; de Wildt SN
    Eur J Clin Pharmacol; 2012 Jan; 68(1):1-10. PubMed ID: 21732178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric investigation plans for pain: painfully slow!
    Davies EH; Ollivier CM; Saint Raymond A
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1091-7. PubMed ID: 20821198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are children getting the right drugs?].
    Bratlid D
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3290-2. PubMed ID: 16327857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.